P

Inventor

PHAN LY TAM

US46 patents
⚠️ This page may combine multiple inventors who share the name “PHAN LY TAM”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

ENANTA PHARM INC

37 patents
US6878691B2Apr 12, 2005

6-11 bicyclic ketolide derivatives

ENANTA PHARM INC73 citations97
US6680299B2Jan 20, 2004

4'-substituted leucomycins

ENANTA PHARM INC71 citations97
US7189704B2Mar 13, 2007

6-11 bicyclic ketolide derivatives

ENANTA PHARM INC15 citations93
US6764998B1Jul 20, 2004

6,11-4C-bicyclic 9a-azalide derivatives

ENANTA PHARM INC39 citations93
US7273853B2Sep 25, 2007

6-11 bicyclic ketolide derivatives

ENANTA PHARM INC35 citations92
US7129221B2Oct 31, 2006

6,11-bicyclic erythromycin derivatives

ENANTA PHARM INC25 citations92
US6645941B1Nov 11, 2003

6,11-3C-bicyclic 9a-azalide derivatives

ENANTA PHARM INC41 citations92
US6436906B1Aug 20, 2002

9-amino-14-membered macrolides derived from leucomycins

ENANTA PHARM INC21 citations91
US6462026B1Oct 8, 2002

Bicyclic leucomycins

ENANTA PHARM INC25 citations90
US7414030B2Aug 19, 2008

6-11 Bicyclic erythromycin derivatives

ENANTA PHARM INC12 citations84
US7402568B2Jul 22, 2008

Bicyclic 9a-azalide derivatives

ENANTA PHARM INC16 citations84
US7384922B2Jun 10, 2008

6-11 bridged oxime erythromycin derivatives

ENANTA PHARM INC14 citations84
US7265094B2Sep 4, 2007

9N-substituted 6-11 bicyclic erythromycin derivatives

ENANTA PHARM INC11 citations84
US7064110B2Jun 20, 2006

6-11 bicycle ketolide derivatives

ENANTA PHARM INC16 citations84
US7049417B2May 23, 2006

6,11-4-Carbon bridged ketolides

ENANTA PHARM INC12 citations84
US6576615B2Jun 10, 2003

4′-O-substituted tylosin analogs

ENANTA PHARM INC14 citations84
US6710034B2Mar 23, 2004

5-O-mycaminosyltylonide derivatives

ENANTA PHARM INC15 citations83
US6753415B2Jun 22, 2004

23-O-substituted 5-O-mycaminosyltylonide derivatives

ENANTA PHARM INC15 citations82
US6664240B2Dec 16, 2003

Tylosin derivatives having antibacterial activity

ENANTA PHARM INC15 citations79
US6753318B1Jun 22, 2004

6,11-4-carbon bridged erythromycin derivatives

ENANTA PHARM INC10 citations74
US6774115B1Aug 10, 2004

6-O-substituted bicyclic ketolides

ENANTA PHARM INC3 citations63
US6716820B1Apr 6, 2004

6-O-substituted bicyclic macrolides

ENANTA PHARM INC4 citations63
US7271155B2Sep 18, 2007

9A, 11-2C-bicyclic 9a-azalide derivatives

ENANTA PHARM INC5 citations62
US6953782B2Oct 11, 2005

11-C-substituted erythromycin derivatives

ENANTA PHARM INC2 citations62
US6765016B1Jul 20, 2004

Bicyclic ketolide derivatives

ENANTA PHARM INC4 citations62
US6720308B1Apr 13, 2004

Anhydrolide derivatives having antibacterial activity

ENANTA PHARM INC7 citations62
US9242974B2Jan 26, 2016

Processes for the preparation of 2-fluoro 6-11 bicyclic erythromycin derivatives

ENANTA PHARM INC0 citations52
US8354383B2Jan 15, 2013

6,11-bridged biaryl macrolides

ENANTA PHARM INC1 citations52
US7276487B2Oct 2, 2007

9a, 11-3C-bicyclic 9a-azalide derivatives

ENANTA PHARM INC1 citations52
US6790835B1Sep 14, 2004

Bicyclic macrolide derivatives

ENANTA PHARM INC1 citations52
US7589067B2Sep 15, 2009

6, 11-bridged tricyclic macrolides

ENANTA PHARM INC1 citations51
US6812216B2Nov 2, 2004

11-C-substituted derivatives of clarithromycin

ENANTA PHARM INC1 citations51
US7842813B2Nov 30, 2010

Processes for the preparation of O-[5-(4-amino-thiazol-2-yl)-pyridin-2-ylmethyl]-hydroxylamine

ENANTA PHARM INC1 citations46
US7622452B2Nov 24, 2009

C-9 alkenylidine bridged macrolides

ENANTA PHARM INC0 citations42
US6750204B2Jun 15, 2004

11-C-substituted ketolides

ENANTA PHARM INC0 citations41
US6727229B2Apr 27, 2004

11,12-substituted lactone ketolide derivatives having antibacterial activity

ENANTA PHARM INC0 citations41
US8383785B2Feb 26, 2013

Anti-bacterial activity of 9-hydroxy derivatives of 6,11-bicyclolides

ENANTA PHARM INC0 citations40

ABBOTT LAB

6 patents

ENANRA PHARMACEUTICALS INC

1 patent

KIM IN JONG

1 patent

XU GUOYOU

1 patent